Do histopathology reports of primary cutaneous melanoma contain enough essential information?

Journal of Clinical Pathology

Volumn 49, Issue 3, 1996, Pages 202-204

  Miller, J M ^a,c   Slater, D N ^b  

^a Department of Public Health   (United Kingdom)

^b Rotherham NHS Foundation Trust   (United Kingdom)

^c Rotherham Health Authorities ^*  (United Kingdom)

Author keywords

Audit; Breslow thickness; Cutaneous malignant melanoma; Excision margins

Indexed keywords

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; QUALITY CONTROL; SKIN CANCER;

EID: 0029988025     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.3.202     Document Type: Article

References (9)

1. Breslow A. Thickness, cross-sectioned areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
2. Rampen FHJ. At least 1 centimetre for each millimetre. BMJ 1984;289:782-3.
3. NHS Management Executive. The Health of the Nation. First Steps for the NHS. London: NHS Management Executive, 1992:16.
4. Green MS, Ackerman AB. Thickness is not an accurate gauge of prognosis of primary cutaneous melanoma. Am J Dermatopathol 1993;15:461-73.
5. Delaunay MM. Prognostic factors in melanoma. In: Kirkham N, Cotton DWK, Lallemand RC, White JE, Rosin RD, eds. Diagnosis and management of melanoma in clinical practice. London: Springer-Verlag, 1902:17-112.
6. Melia J, Ellman R, Chamberlain J. Meeting the Health of the Nation target for skin cancer: problems with tackling prevention and monitoring trends. J Public Health Med 1994;16:225-32.
7. Timmons MJ. Malignant melanoma excision margins: making a choice. Lancet 1992;340:1393-5.
8. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-19.
9. Miller J, Irving F, MacLeod C. Health Gain Investment Programme Technical Review Document - Skin cancers. Sheffield: Trent Regional Health Authority, (in press).